NCT00134537

Brief Summary

The purpose of this study is to compare improvement in low back pain with Wallis (interspinous process implant) to exercise and injections.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P50-P75 for phase_3 low-back-pain

Timeline
Completed

Started Nov 2004

Longer than P75 for phase_3 low-back-pain

Geographic Reach
1 country

17 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2004

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 23, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 25, 2005

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

October 4, 2011

Status Verified

October 1, 2011

Enrollment Period

6.4 years

First QC Date

August 23, 2005

Last Update Submit

October 3, 2011

Conditions

Keywords

Degenerative Disc Disease of the lumbar spine

Outcome Measures

Primary Outcomes (1)

  • To provide a safety cohort for the Prospective, Multi-center, Randomized, Active-Controlled Study of the Wallis System for the Treatment of Mild to Moderate Degenerative Disc Disease of the Lumbar Spine

    24 months

Study Arms (2)

1

EXPERIMENTAL

Interspinous process and dynamic stabilization

Device: Interspinous process and dynamic stabilization

2

ACTIVE COMPARATOR

Conservative Care

Device: Conservative Care

Interventions

Interspinous process and dynamic stabilization

1

Medication, exercise and spinal injections

2

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may not qualify if:

  • Ages 18-60; male/female.
  • Diagnosis of mild to moderate degenerative disc disease (DDD), which requires:
  • back pain of at least 30/100 as measured on a visual analog scale, with or without leg (radicular) pain; and
  • radiographic confirmation of the following, as determined by computed tomography (CT), magnetic resonance imaging (MRI), discography, plain film, myelography and/or flexion/extension films: up to Modic I changes on MRI, with decreased disc height up to 50% of adjacent level, and no significant osteophytes; with or without a contained disc herniation.
  • Candidate for either surgery with Wallis or aggressive conservative management.
  • Requires treatment at one or two lumbar levels between L1 and L5.
  • Experienced symptoms for at least three months without significant resolution.
  • Has undergone a regimen of at least four weeks of anti-inflammatory medication for the current episode of back pain and had exposure to physical therapy.
  • Minimum baseline Oswestry score of 30% (15/50).
  • Physically and mentally able to comply with the protocol, including ability to read and complete required forms, and willing and able to adhere to the follow-up requirements of the protocol.
  • Voluntarily signs the subject informed consent.
  • Significant neuroforaminal compression requiring discectomy or foraminotomy
  • Radiographic evidence of DDD at L5-S1
  • Radiographic confirmation of severe facet joint disease or degeneration.
  • History of any lumbar disc treatment intended to remove the disc, e.g. surgery, intradiscal electrothermal therapy (IDET), laser or enzymes such as chymopapain.
  • +27 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (17)

Spine Specialists of Arizona

Phoenix, Arizona, 85015, United States

Location

Arizona Institute for Minimally Invasive Spine Care

Phoenix, Arizona, 85020, United States

Location

Spine Source

Beverly Hills, California, 90212, United States

Location

UCLA Spine Center

Santa Monica, California, 90404, United States

Location

Boulder Neurosurgical Associates

Boulder, Colorado, 80304, United States

Location

The Spine Education & Research Institute

Thornton, Colorado, 80229, United States

Location

Emory University Medical Center

Atlanta, Georgia, 30329, United States

Location

Illinois Bone & Joint Institute

Morton Grove, Illinois, 60053, United States

Location

Fort Wayne Orthopedics

Fort Wayne, Indiana, 46804, United States

Location

Greater Baltimore Medical Center

Baltimore, Maryland, 21204, United States

Location

Orthopaedic Associates

Towson, Maryland, 21204, United States

Location

The Orthopedic Center of St. Louis

Chesterfield, Missouri, 63017, United States

Location

Orthopedic Spine Care of Long Island

Melville, New York, 11747, United States

Location

Orthopedic Spine Associates

Eugene, Oregon, 97401, United States

Location

The Orthopedic Specialty Center (Abington Hospital)

Willow Grove, Pennsylvania, 19090, United States

Location

Central Texas Spine Institute

Austin, Texas, 78731, United States

Location

TBI/ Plano Presbyterian Hospital

Plano, Texas, 75093, United States

Location

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2005

First Posted

August 25, 2005

Study Start

November 1, 2004

Primary Completion

April 1, 2011

Study Completion

April 1, 2012

Last Updated

October 4, 2011

Record last verified: 2011-10

Locations